Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Eritoran

Base Information Edit
  • Chemical Name:Eritoran
  • CAS No.:185955-34-4
  • Deprecated CAS:261504-30-7
  • Molecular Formula:C66H126N2O19P2
  • Molecular Weight:1313.66
  • Hs Code.:
  • UNII:551541VI0Y
  • DSSTox Substance ID:DTXSID60873217
  • Nikkaji Number:J2.041.121J
  • Wikipedia:Eritoran
  • Wikidata:Q5389586
  • NCI Thesaurus Code:C80053
  • Pharos Ligand ID:26265KQ81MV8,262WGWS37117
  • Metabolomics Workbench ID:65121
  • ChEMBL ID:CHEMBL501259
  • Mol file:185955-34-4.mol
Eritoran

Synonyms:3-O-decyl-2-deoxy-6-O-(2-deoxy-3-O-(3-methoxydecyl)-6-O-methyl-2-((1-oxo-11-octadecenyl)amino)-4-O-phosphonoglucopyranosyl)-2-((1,3-dioxotetradecyl)amino)-1-(dihydroxy phosphate)glucopyranose;eritoran

Suppliers and Price of Eritoran
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • American Custom Chemicals Corporation
  • ERITORAN 95.00%
  • 5MG
  • $ 499.71
Total 52 raw suppliers
Chemical Property of Eritoran Edit
Chemical Property:
  • PKA:1.73±0.10(Predicted) 
  • PSA:324.57000 
  • Density:1.14g/cm3 
  • LogP:16.14580 
  • XLogP3:15.4
  • Hydrogen Bond Donor Count:7
  • Hydrogen Bond Acceptor Count:19
  • Rotatable Bond Count:59
  • Exact Mass:1312.84300379
  • Heavy Atom Count:89
  • Complexity:1900
Purity/Quality:

98% *data from raw suppliers

ERITORAN 95.00% *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Canonical SMILES:CCCCCCCCCCCC(=O)CC(=O)NC1C(C(C(OC1OP(=O)(O)O)COC2C(C(C(C(O2)COC)OP(=O)(O)O)OCCC(CCCCCCC)OC)NC(=O)CCCCCCCCCC=CCCCCCC)O)OCCCCCCCCCC
  • Isomeric SMILES:CCCCCCCCCCCC(=O)CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1OP(=O)(O)O)CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)COC)OP(=O)(O)O)OCC[C@@H](CCCCCCC)OC)NC(=O)CCCCCCCCC/C=C\CCCCCC)O)OCCCCCCCCCC
  • Recent ClinicalTrials:Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
  • Recent EU Clinical Trials:ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients with Severe Sepsis
  • Recent NIPH Clinical Trials:REMAP-CAP:Randomized,Embedded,Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia Immune Modulation-2 Domain
  • Uses Treatment of sepsis and other diseases due to reaction to bacterial endotoxin (endotoxin antagonist).
Post RFQ for Price